Point72 Asset Management
CPRX

Point72 Asset Management’s Catalyst Pharmaceutical CPRX Stock Holding History

Point72 Asset Management’s Portfolio CPRX Stock Details CPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$10.5M Buy
+425,865
New +$10.1M 0.01% 1212
2024
Q3 		– Sell
-618,296
Closed -$9.58M – 2039
2024
Q2 		$9.58M Buy
618,296
+200,370
+48% +$3.12M 0.03% 632
2024
Q1 		$6.66M Sell
417,926
-78,665
-16% -$1.19M 0.02% 874
2023
Q4 		$8.35M Buy
496,591
+300,280
+153% +$4.1M 0.02% 743
2023
Q3 		$2.29M Buy
+196,311
New +$2.63M 0.01% 1105
2023
Q2 		– Sell
-1,470
Closed -$24.4K – 2258
2023
Q1 		$24.4K Buy
+1,470
New +$24.3K ﹤0.01% 1942
2020
Q4 		– Sell
-50,000
Closed -$149K – 944
2020
Q3 		$149K Buy
+50,000
New +$196K ﹤0.01% 878
2017
Q2 		– Sell
-877,266
Closed -$1.71M – 853
2017
Q1 		$1.71M Sell
877,266
-1,395,550
-61% -$1.78M 0.01% 685
2016
Q4 		$2.39M Sell
2,272,816
-94,148
-4% -$108K 0.02% 545
2016
Q3 		$2.58M Hold
2,366,964
– – 0.02% 530
2016
Q2 		$1.68M Buy
2,366,964
+103,388
+5% +$83.3K 0.01% 580
2016
Q1 		$2.65M Sell
2,263,576
-13,347
-0.6% -$20.7K 0.02% 531
2015
Q4 		$5.58M Buy
2,276,923
+70,659
+3% +$202K 0.05% 395
2015
Q3 		$6.62M Sell
2,206,264
-1,257,541
-36% -$5.43M 0.05% 381
2015
Q2 		$14.3M Sell
3,463,805
-3,104,195
-47% -$12.4M 0.1% 265
2015
Q1 		$28.4M Buy
6,568,000
+3,068,000
+88% +$11.1M 0.19% 155
2014
Q4 		$10.4M Buy
+3,500,000
New +$9.6M 0.07% 319

Other funds holding CPRX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Point72 Asset Management's CPRX Position: Q1 2026 in Review

Point72 Asset Management opened a new position in Catalyst Pharmaceutical (CPRX) in Q1 2026: 425,865 shares worth $10.5M. The stake represents 0.01% of the portfolio and ranks #1212 among its holdings. This is a return to the name: Point72 Asset Management previously reported a position in CPRX as recently as Q2 2024.

Point72 Asset Management first reported a position in CPRX in Q4 2014 and has held it in 17 quarters since. The position peaked at $28.4M in Q1 2015. 380 funds tracked by Wall St. Rank hold CPRX as of Q1 2026.

  • Point72 Asset Management held 425,865 shares of Catalyst Pharmaceutical worth $10.5M as of Q1 2026.
  • Catalyst Pharmaceutical was a new Point72 Asset Management position in Q1 2026.
  • Catalyst Pharmaceutical made up 0.01% of Point72 Asset Management's portfolio in Q1 2026, its #1212 holding.
  • Point72 Asset Management first reported a position in Catalyst Pharmaceutical in Q4 2014 and has held it in 17 quarters since.
  • Point72 Asset Management's Catalyst Pharmaceutical position peaked at $28.4M in Q1 2015.
  • 380 funds tracked by Wall St. Rank held Catalyst Pharmaceutical as of Q1 2026.

Based on Point72 Asset Management's 13F filing for Q1 2026, filed 15 May 2026.